IRIS Accounts Production v23.3.1.45 14108307 Board of Directors Board of Directors 16.5.22 31.5.23 31.5.23 0 false true false false true false ORDINARY 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh141083072022-05-15141083072023-05-31141083072022-05-162023-05-31141083072022-05-1514108307ns10:Originalns15:EnglandWales2022-05-162023-05-3114108307ns14:PoundSterlingns10:Original2022-05-162023-05-3114108307ns10:Originalns10:Director12022-05-162023-05-3114108307ns10:Original2022-05-162023-05-3114108307ns10:Originalns10:Director22022-05-162023-05-3114108307ns10:Original2023-05-3114108307ns10:Originalns10:PrivateLimitedCompanyLtd2022-05-162023-05-3114108307ns10:Originalns10:SmallEntities2022-05-162023-05-3114108307ns10:Originalns10:AuditExemptWithAccountantsReport2022-05-162023-05-3114108307ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-05-162023-05-3114108307ns10:SmallCompaniesRegimeForAccountsns10:Original2022-05-162023-05-3114108307ns10:Originalns10:FullAccounts2022-05-162023-05-3114108307ns10:Originalns10:OrdinaryShareClass12022-05-162023-05-3114108307ns10:Originalns10:OrdinaryShareClass112022-05-162023-05-3114108307ns10:Originalns10:RegisteredOffice2022-05-162023-05-3114108307ns10:Originalns5:CurrentFinancialInstruments2023-05-3114108307ns5:ShareCapitalns10:Original2023-05-3114108307ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-05-3114108307ns10:Originalns5:LandBuildings2022-05-162023-05-3114108307ns10:Originalns5:PlantMachinery2022-05-162023-05-3114108307ns10:Originalns5:LandBuildings2023-05-3114108307ns10:Originalns5:PlantMachinery2023-05-3114108307ns5:AcceleratedTaxDepreciationDeferredTaxns10:Original2023-05-3114108307ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-05-3114108307ns10:Originalns5:WithinOneYear2023-05-3114108307ns5:BetweenOneFiveYearsns10:Original2023-05-3114108307ns10:Originalns5:MoreThanFiveYears2023-05-3114108307ns10:Originalns5:AllPeriods2023-05-3114108307ns10:Originalns5:DeferredTaxation2022-05-162023-05-3114108307ns10:Originalns5:DeferredTaxation2023-05-3114108307ns10:Originalns10:OrdinaryShareClass12023-05-3114108307ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-05-162023-05-31
REGISTERED NUMBER: 14108307 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023

FOR

CRYOHEALTH (SOUTHGATE) LTD

CRYOHEALTH (SOUTHGATE) LTD (REGISTERED NUMBER: 14108307)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3

Chartered Accountants' Report 6

CRYOHEALTH (SOUTHGATE) LTD

COMPANY INFORMATION
FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023







DIRECTORS: Mr B. Auladin
Mr N Janahan





REGISTERED OFFICE: 4 The Broadway
Southgate
London
N14 6PH





REGISTERED NUMBER: 14108307 (England and Wales)





ACCOUNTANTS: Chris Skarparis & Co Ltd
Chartered Accountants
2nd Floor
10(b) Aldermans Hill
Palmers Green
London
N13 4PJ

CRYOHEALTH (SOUTHGATE) LTD (REGISTERED NUMBER: 14108307)

BALANCE SHEET
31 MAY 2023

Notes £    £   
FIXED ASSETS
Tangible assets 4 136,893

CURRENT ASSETS
Stocks 1,083
Debtors 5 43,917
Cash at bank 31,250
76,250
CREDITORS
Amounts falling due within one year 6 246,574
NET CURRENT LIABILITIES (170,324 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(33,431

)

CAPITAL AND RESERVES
Called up share capital 9 100
Retained earnings 10 (33,531 )
SHAREHOLDERS' FUNDS (33,431 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 February 2024 and were signed on its behalf by:



Mr B. Auladin - Director



Mr N Janahan - Director


CRYOHEALTH (SOUTHGATE) LTD (REGISTERED NUMBER: 14108307)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023

1. STATUTORY INFORMATION

CryoHealth (Southgate) Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - written off over the life of the lease
Plant and machinery etc - 25% on reducing balance and 15% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Going concern
As with most businesses the Company has been affected by the ongoing impact of Covid-19, the exit from the European Union and the high level of inflation in the UK economy. These have had an impact on the operations, customers, suppliers and staff. The Company is taking all the steps it can to protect the future of the business. Although the total impact is still uncertain the director believes that it is appropriate to prepare the accounts on a going concern basis.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was NIL.

CRYOHEALTH (SOUTHGATE) LTD (REGISTERED NUMBER: 14108307)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023

4. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
Additions 9,034 162,797 171,831
At 31 May 2023 9,034 162,797 171,831
DEPRECIATION
Charge for period - 34,035 34,035
Impairments 903 - 903
At 31 May 2023 903 34,035 34,938
NET BOOK VALUE
At 31 May 2023 8,131 128,762 136,893

5. DEBTORS
£   
Amounts falling due within one year:
VAT 3,439
Deferred tax asset
Accelerated capital allowances 21,474
Prepayments 7,429
32,342

Amounts falling due after more than one year:
Rent Deposit 11,575

Aggregate amounts 43,917

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Directors' current accounts 245,949
Accrued expenses 625
246,574

7. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
£   
Within one year 12,625
Between one and five years 92,600
In more than five years 126,275
231,500

CRYOHEALTH (SOUTHGATE) LTD (REGISTERED NUMBER: 14108307)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 16 MAY 2022 TO 31 MAY 2023

8. DEFERRED TAX
£   
Credit to Income Statement during period (21,474 )
Balance at 31 May 2023 (21,474 )

9. CALLED UP SHARE CAPITAL

Allotted and issued:
Number: Class: Nominal
value: £   
100 Share capital 1 £1 100

100 ORDINARY shares of £1 each were allotted at par during the period.

10. RESERVES
Retained
earnings
£   

Deficit for the period (33,531 )
At 31 May 2023 (33,531 )

11. GOING CONCERN

The financial statements have been prepared on a going concern basis on the assumption that the directors will continue supporting the company. As at 31 May 2023, the company had Net Liabilities of £33,431.

The directors have provided assurances that they will continue supporting the company to meet its obligations as they fall due by providing loans.

The directors believe that in the following years the results will improve leading to a strengthening of the company's balance sheet.

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
CRYOHEALTH (SOUTHGATE) LTD

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of CryoHealth (Southgate) Ltd for the period ended 31 May 2023 which comprise the Income Statement, Balance Sheet, Statement of Changes in Equity and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of CryoHealth (Southgate) Ltd, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of CryoHealth (Southgate) Ltd and state those matters that we have agreed to state to the Board of Directors of CryoHealth (Southgate) Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than CryoHealth (Southgate) Ltd and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that CryoHealth (Southgate) Ltd has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of CryoHealth (Southgate) Ltd. You consider that CryoHealth (Southgate) Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of CryoHealth (Southgate) Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Chris Skarparis & Co Ltd
Chartered Accountants
2nd Floor
10(b) Aldermans Hill
Palmers Green
London
N13 4PJ


8 February 2024